|
|
|
Hecus XRS |
 |
| |
|
Hecus is the leading, specialised innovator in the field of small- and wide-angle x-ray scattering, S/WAXS. We have turned SAXS-instruments into a practical tool for non-destructive laboratory testing.
Hecus XRS offers the widest range of laboratory X-ray tools:
- S3-MICROcaliX, the latest innovation is just being released: a combination between S/WAXS camera and Microcalorimeter. This absolutely new and unique solution is only available at Hecus and will improve every chemical and pharmaceutical laboratory.
- The S3-MICRO-series meets highest demands in R&D with point-focussing optics combined with 2D-CCD- or Pixel-detectors.
- The System3-series is the routine laboratory solution with line-focussing optics and 1D- or 2D-detectors.
- S3-MICROpix, the latest and most advanced SAXS-system on the market, is providing highest brilliance, economy and ultimate performance.
Moreover, Hecus offers a wide variety of accessories:
- temperature controls (ranges from -20 to +300°C)
- various sample cells (for liquids, solids, pastes & powders)
- SpinCap for capillary rotation
- GISAXS Micro Rotation Stage for thin-film measurements
- environmental cell under pressures of up to 10 MPa (100 bar) for absolute-scale SWAXS studies on gas or vapour sorption effects in porous materials.
Applications: protein solution SAXS, nanoparticle sizing, thin-film structure analysis, LC phase mapping, nanopowder porosity. |
|
|
|
|
|
| |
|
|
|
|
|
 |
Industry Events |
 |
Pharmapack Europe 2012
15-16 February 2012, Grande Halle de la Villette, Paris, France
Confirming its continuous expansion, the show will welcome a higher number of participants than last year, with 2,800 visitors from 50 countries expected to join the 250 exhibitors at the Grande Halle de la Villette.
More info >> |
|
 |
News and Press Releases |
 |
AMRI Announces Preferred Provider Agreement with BioPontis Alliance LLC
AMRI, a global contract services organization, announced today that it has entered into a preferred provider agreement with BioPontis Alliance LLC. The agreement is aimed at supporting BioPontis’ mission to bridge the gap between early-stage research and technologies being discovered and developed in academia and other research entities. AMRI will provide its services in small molecule discovery, development, and manufacturing in BioPontis’ drug discovery research programs. The agreement also supports the need for proof-of-concept data that is required in the current pharmaceutical company licensing environment. The goal of BioPontis Alliance is to identify promising early stage product opportunities and utilize a preferred network of CROs and leading research companies to apply appropriate expertise to develop these opportunities enough to attract pharmaceutical company licensing partners.
More info >> |
|
|
|
